Cancer Institute of New Jersey (CINJ), Hematologic Malignancies

Fingerprint Dive into the research topics where Cancer Institute of New Jersey (CINJ), Hematologic Malignancies is active. These topic labels come from the works of this organization's members. Together they form a unique fingerprint.

  • Network Recent external collaboration on country level. Dive into details by clicking on the dots.

    Research Output

    Checkpoint blockade treatment sensitises relapsed/refractory non-Hodgkin lymphoma to subsequent therapy

    Carreau, N. A., Armand, P., Merryman, R. W., Advani, R. H., Spinner, M. A., Herrera, A. F., Ramchandren, R., Hamid, M. S., Assouline, S., Santiago, R., Wagner-Johnston, N., Paul, S., Svoboda, J., Bair, S. M., Barta, S. K., Nathan, S., Karmali, R., Torka, P., David, K., Lansigan, F. & 5 others, Persky, D., Godfrey, J., Chavez, J. C., Xia, Y. & Diefenbach, C., Jan 1 2020, (Accepted/In press) In : British Journal of Haematology.

    Research output: Contribution to journalArticle

  • 3 Scopus citations

    Current Treatment Options for Older Patients with Hodgkin Lymphoma

    Carter, J., David, K. A., Kritharis, A. & Evens, A. M., May 1 2020, In : Current treatment options in oncology. 21, 5, 42.

    Research output: Contribution to journalReview article

  • How I treat advanced Hodgkin lymphoma — a global view

    Hokland, P., Shah, M., David, K., Evens, A., Auer, R., Ledieu, R., Kreissl, S., Bröckelmann, P. J., Borchmann, P., Korula, A., Mathews, V., Owattanapanich, W. & Trotman, J., 2020, (Accepted/In press) In : British Journal of Haematology.

    Research output: Contribution to journalArticle

    Open Access